How Allergan Beat Estimates in What's Likely Its Last Quarterly Update

Allergan (NYSE: AGN) entered 2020 with a lot of momentum. AbbVie's (NYSE: ABBV) announcement of its plans to acquire Allergan gave the stock a big boost. That news was so great that investors didn't care that Allergan delivered less-than-exciting third-quarter results in November.